Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Hyperplasia | 6 | 2021 | 514 | 1.170 |
Why?
|
Embolization, Therapeutic | 12 | 2021 | 1403 | 1.110 |
Why?
|
Radiology, Interventional | 9 | 2022 | 483 | 1.020 |
Why?
|
Uterine Artery Embolization | 4 | 2024 | 62 | 0.980 |
Why?
|
Adrenal Cortex Neoplasms | 2 | 2017 | 161 | 0.970 |
Why?
|
Adrenalectomy | 2 | 2017 | 347 | 0.940 |
Why?
|
Catheter Ablation | 11 | 2021 | 2787 | 0.930 |
Why?
|
Hyperaldosteronism | 2 | 2017 | 252 | 0.860 |
Why?
|
Prostate | 7 | 2021 | 1761 | 0.800 |
Why?
|
Radiography, Interventional | 8 | 2020 | 1129 | 0.790 |
Why?
|
Aneurysm, False | 1 | 2024 | 263 | 0.770 |
Why?
|
Thrombin | 1 | 2024 | 600 | 0.770 |
Why?
|
Aldosterone | 2 | 2017 | 881 | 0.760 |
Why?
|
Upper Extremity | 1 | 2024 | 684 | 0.640 |
Why?
|
Hepatic Artery | 2 | 2018 | 233 | 0.580 |
Why?
|
After-Hours Care | 1 | 2018 | 102 | 0.570 |
Why?
|
Adrenocortical Adenoma | 1 | 2017 | 46 | 0.550 |
Why?
|
Leiomyoma | 6 | 2024 | 644 | 0.530 |
Why?
|
Ultrasonography, Interventional | 2 | 2024 | 1523 | 0.530 |
Why?
|
Blood Pressure Determination | 1 | 2018 | 646 | 0.450 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2015 | 95 | 0.440 |
Why?
|
Tetracycline | 3 | 2002 | 216 | 0.410 |
Why?
|
Magnetic Resonance Angiography | 3 | 2016 | 1429 | 0.400 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2015 | 296 | 0.390 |
Why?
|
Surgery, Computer-Assisted | 3 | 2013 | 996 | 0.370 |
Why?
|
Arteries | 6 | 2021 | 1123 | 0.330 |
Why?
|
Bacterial Translocation | 4 | 2002 | 74 | 0.320 |
Why?
|
Uterine Neoplasms | 5 | 2024 | 1424 | 0.310 |
Why?
|
Liver Diseases | 2 | 2015 | 1304 | 0.310 |
Why?
|
Radial Artery | 2 | 2020 | 187 | 0.310 |
Why?
|
Antibiotic Prophylaxis | 3 | 2002 | 640 | 0.290 |
Why?
|
Ischemia | 1 | 2016 | 1905 | 0.280 |
Why?
|
Catheterization, Peripheral | 2 | 2020 | 346 | 0.270 |
Why?
|
Adenoma | 2 | 2016 | 2155 | 0.260 |
Why?
|
Renal Dialysis | 2 | 2022 | 1790 | 0.260 |
Why?
|
Catheterization, Central Venous | 2 | 2008 | 537 | 0.260 |
Why?
|
Escherichia coli Infections | 4 | 2002 | 518 | 0.230 |
Why?
|
Bile Duct Neoplasms | 2 | 2021 | 614 | 0.220 |
Why?
|
Omeprazole | 1 | 2004 | 106 | 0.220 |
Why?
|
Hypertension | 3 | 2018 | 8615 | 0.210 |
Why?
|
Hemostatics | 2 | 2024 | 247 | 0.210 |
Why?
|
Liver Neoplasms | 4 | 2021 | 4357 | 0.210 |
Why?
|
Retrospective Studies | 25 | 2024 | 81659 | 0.210 |
Why?
|
Brachial Artery | 1 | 2024 | 373 | 0.210 |
Why?
|
Hemorrhage | 1 | 2015 | 3464 | 0.210 |
Why?
|
Esophagitis | 1 | 2004 | 164 | 0.200 |
Why?
|
Acute Kidney Injury | 1 | 2015 | 1946 | 0.200 |
Why?
|
Contrast Media | 2 | 2015 | 5329 | 0.200 |
Why?
|
Liver Transplantation | 2 | 2018 | 2416 | 0.200 |
Why?
|
Fibroadenoma | 1 | 2021 | 42 | 0.190 |
Why?
|
Treatment Outcome | 21 | 2024 | 65295 | 0.190 |
Why?
|
Bronchodilator Agents | 1 | 2004 | 513 | 0.180 |
Why?
|
Short Bowel Syndrome | 2 | 2020 | 352 | 0.180 |
Why?
|
Transurethral Resection of Prostate | 1 | 2021 | 77 | 0.180 |
Why?
|
Liver | 2 | 2018 | 7578 | 0.170 |
Why?
|
Drug Costs | 1 | 2018 | 1196 | 0.170 |
Why?
|
Glucagon-Like Peptide 2 | 1 | 2020 | 45 | 0.170 |
Why?
|
Antidiarrheals | 1 | 2020 | 46 | 0.170 |
Why?
|
Graft Survival | 3 | 2018 | 3896 | 0.170 |
Why?
|
Electromagnetic Phenomena | 1 | 2020 | 159 | 0.170 |
Why?
|
Thrombectomy | 1 | 2004 | 676 | 0.170 |
Why?
|
Gelatin Sponge, Absorbable | 1 | 2019 | 56 | 0.170 |
Why?
|
Parenteral Nutrition, Home | 1 | 2020 | 39 | 0.160 |
Why?
|
Eosinophilia | 1 | 2004 | 554 | 0.160 |
Why?
|
Graft Occlusion, Vascular | 2 | 2022 | 538 | 0.160 |
Why?
|
Lung | 3 | 2021 | 10076 | 0.160 |
Why?
|
Sepsis | 3 | 2002 | 2605 | 0.160 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2022 | 291 | 0.160 |
Why?
|
Venous Thrombosis | 1 | 2008 | 1321 | 0.160 |
Why?
|
Peer Review, Health Care | 1 | 2019 | 73 | 0.150 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2020 | 195 | 0.150 |
Why?
|
Uterine Hemorrhage | 1 | 2019 | 236 | 0.150 |
Why?
|
Nerve Block | 1 | 2024 | 717 | 0.140 |
Why?
|
Motor Skills | 1 | 2020 | 521 | 0.140 |
Why?
|
Middle Aged | 27 | 2024 | 223233 | 0.140 |
Why?
|
Intention to Treat Analysis | 1 | 2018 | 418 | 0.140 |
Why?
|
Hypnosis | 2 | 2008 | 83 | 0.140 |
Why?
|
Humans | 54 | 2024 | 767040 | 0.130 |
Why?
|
Gastroesophageal Reflux | 1 | 2004 | 834 | 0.130 |
Why?
|
Catheters, Indwelling | 2 | 2010 | 436 | 0.130 |
Why?
|
Cryosurgery | 1 | 2021 | 479 | 0.130 |
Why?
|
Female | 33 | 2024 | 396660 | 0.130 |
Why?
|
Kidney Failure, Chronic | 1 | 2008 | 2495 | 0.130 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 561 | 0.130 |
Why?
|
Nitric Oxide | 1 | 2004 | 2140 | 0.130 |
Why?
|
Postpartum Hemorrhage | 1 | 2019 | 275 | 0.130 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4210 | 0.120 |
Why?
|
Femoral Artery | 1 | 2019 | 827 | 0.120 |
Why?
|
Hand | 1 | 2020 | 910 | 0.120 |
Why?
|
Adrenal Gland Neoplasms | 2 | 2011 | 733 | 0.120 |
Why?
|
Graft Rejection | 1 | 2018 | 4498 | 0.120 |
Why?
|
Triiodobenzoic Acids | 1 | 2015 | 124 | 0.120 |
Why?
|
Brazil | 2 | 2016 | 1250 | 0.120 |
Why?
|
Angioplasty, Balloon | 1 | 2018 | 592 | 0.120 |
Why?
|
Teaching Rounds | 1 | 2019 | 282 | 0.120 |
Why?
|
Boston | 3 | 2016 | 9360 | 0.110 |
Why?
|
Cholestasis | 1 | 2017 | 385 | 0.110 |
Why?
|
End Stage Liver Disease | 1 | 2018 | 369 | 0.110 |
Why?
|
Telemedicine | 2 | 2022 | 3110 | 0.110 |
Why?
|
Male | 27 | 2024 | 364203 | 0.110 |
Why?
|
Gelatin | 2 | 2012 | 227 | 0.110 |
Why?
|
Length of Stay | 2 | 2018 | 6489 | 0.110 |
Why?
|
Radiology Information Systems | 1 | 2017 | 535 | 0.110 |
Why?
|
Fluoroscopy | 1 | 2017 | 948 | 0.110 |
Why?
|
Terminology as Topic | 1 | 2020 | 1540 | 0.100 |
Why?
|
Patient Care Planning | 2 | 2017 | 903 | 0.100 |
Why?
|
Intestines | 2 | 2020 | 1905 | 0.100 |
Why?
|
Time Factors | 8 | 2024 | 40154 | 0.100 |
Why?
|
Angiography | 2 | 2009 | 1597 | 0.100 |
Why?
|
Biopsy | 3 | 2020 | 6777 | 0.100 |
Why?
|
Rats, Wistar | 5 | 2002 | 1885 | 0.090 |
Why?
|
Patient Discharge | 1 | 2024 | 3467 | 0.090 |
Why?
|
Breast Neoplasms | 2 | 2021 | 21178 | 0.090 |
Why?
|
Adult | 22 | 2024 | 223317 | 0.090 |
Why?
|
Pulmonary Embolism | 1 | 2004 | 2598 | 0.090 |
Why?
|
Ablation Techniques | 1 | 2013 | 255 | 0.090 |
Why?
|
Patient Readmission | 1 | 2024 | 3283 | 0.090 |
Why?
|
Aged | 13 | 2024 | 171319 | 0.090 |
Why?
|
Yttrium Radioisotopes | 2 | 2021 | 116 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 4 | 2021 | 36582 | 0.080 |
Why?
|
Learning | 1 | 2019 | 1754 | 0.080 |
Why?
|
Creatinine | 1 | 2015 | 1916 | 0.080 |
Why?
|
Punctures | 2 | 2020 | 371 | 0.080 |
Why?
|
Aged, 80 and over | 6 | 2024 | 59548 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 2330 | 0.080 |
Why?
|
Sonication | 1 | 2009 | 79 | 0.080 |
Why?
|
Bombesin | 1 | 2008 | 35 | 0.080 |
Why?
|
Colectomy | 1 | 2013 | 696 | 0.080 |
Why?
|
Organotechnetium Compounds | 1 | 2008 | 134 | 0.070 |
Why?
|
Equipment Design | 2 | 2013 | 3489 | 0.070 |
Why?
|
Microspheres | 2 | 2021 | 774 | 0.070 |
Why?
|
Clinical Competence | 2 | 2020 | 4859 | 0.070 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2008 | 189 | 0.070 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2008 | 128 | 0.070 |
Why?
|
Risk Factors | 7 | 2024 | 74886 | 0.070 |
Why?
|
Pancreas Transplantation | 1 | 2008 | 194 | 0.070 |
Why?
|
Catheterization | 2 | 2010 | 1430 | 0.070 |
Why?
|
Vascular Patency | 2 | 2022 | 915 | 0.070 |
Why?
|
Bacteria | 1 | 2018 | 2212 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 1 | 2010 | 488 | 0.070 |
Why?
|
Venous Insufficiency | 1 | 2008 | 109 | 0.070 |
Why?
|
Antihypertensive Agents | 1 | 2016 | 2030 | 0.070 |
Why?
|
Femoral Vein | 1 | 2007 | 156 | 0.070 |
Why?
|
Hepatectomy | 1 | 2010 | 589 | 0.070 |
Why?
|
Italy | 1 | 2018 | 856 | 0.070 |
Why?
|
Empathy | 2 | 2008 | 474 | 0.070 |
Why?
|
Blood Coagulation | 2 | 2009 | 1163 | 0.060 |
Why?
|
Diabetic Foot | 1 | 2010 | 382 | 0.060 |
Why?
|
Foot | 1 | 2010 | 576 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 7 | 2016 | 20741 | 0.060 |
Why?
|
Laser Coagulation | 1 | 2008 | 335 | 0.060 |
Why?
|
Relaxation Therapy | 1 | 2006 | 181 | 0.060 |
Why?
|
Arteriovenous Fistula | 1 | 2008 | 320 | 0.060 |
Why?
|
Hypogastric Plexus | 1 | 2024 | 16 | 0.060 |
Why?
|
Vena Cava Filters | 1 | 2008 | 270 | 0.060 |
Why?
|
Saphenous Vein | 1 | 2008 | 519 | 0.060 |
Why?
|
Patient Selection | 2 | 2013 | 4256 | 0.060 |
Why?
|
Peripheral Arterial Disease | 1 | 2016 | 1304 | 0.060 |
Why?
|
Consensus | 3 | 2020 | 3207 | 0.060 |
Why?
|
Cimetidine | 1 | 2004 | 76 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2018 | 5345 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6210 | 0.060 |
Why?
|
2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2004 | 31 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8048 | 0.060 |
Why?
|
Niacinamide | 2 | 2021 | 417 | 0.060 |
Why?
|
Uterus | 1 | 2008 | 661 | 0.060 |
Why?
|
Leukocyte Count | 1 | 2008 | 1606 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3964 | 0.060 |
Why?
|
Suction | 1 | 2004 | 268 | 0.050 |
Why?
|
Transplantation Tolerance | 1 | 2018 | 639 | 0.050 |
Why?
|
Cost Savings | 1 | 2018 | 904 | 0.050 |
Why?
|
Ureteral Calculi | 1 | 2004 | 111 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14672 | 0.050 |
Why?
|
Escherichia coli | 3 | 2000 | 4209 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5389 | 0.050 |
Why?
|
Ambulatory Care | 2 | 2024 | 2780 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3112 | 0.050 |
Why?
|
Histamine H2 Antagonists | 1 | 2004 | 169 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3234 | 0.050 |
Why?
|
Blood Pressure | 1 | 2018 | 8531 | 0.050 |
Why?
|
Ureteral Obstruction | 1 | 2004 | 293 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3530 | 0.050 |
Why?
|
Colony-Forming Units Assay | 1 | 2002 | 351 | 0.050 |
Why?
|
Esophagoscopy | 1 | 2004 | 398 | 0.050 |
Why?
|
Stents | 3 | 2022 | 3193 | 0.050 |
Why?
|
Administration, Inhalation | 1 | 2004 | 1154 | 0.050 |
Why?
|
Vena Cava, Inferior | 2 | 2002 | 463 | 0.050 |
Why?
|
Biopsy, Needle | 1 | 2006 | 1615 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20169 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2009 | 1596 | 0.040 |
Why?
|
Vascular Surgical Procedures | 1 | 2009 | 1506 | 0.040 |
Why?
|
Tetracyclines | 1 | 2000 | 64 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4855 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8736 | 0.040 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2021 | 304 | 0.040 |
Why?
|
Thrombolytic Therapy | 1 | 2009 | 2054 | 0.040 |
Why?
|
Dilatation and Curettage | 1 | 2019 | 53 | 0.040 |
Why?
|
Pregnancy | 2 | 2019 | 30238 | 0.040 |
Why?
|
Rats | 5 | 2002 | 23713 | 0.040 |
Why?
|
Postoperative Complications | 3 | 2011 | 15824 | 0.040 |
Why?
|
Prednisone | 1 | 2004 | 1566 | 0.040 |
Why?
|
Blood Glucose | 1 | 2013 | 6421 | 0.040 |
Why?
|
Prognosis | 2 | 2016 | 29963 | 0.040 |
Why?
|
Palliative Care | 1 | 2013 | 3641 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2018 | 5537 | 0.040 |
Why?
|
Forms and Records Control | 1 | 2019 | 158 | 0.040 |
Why?
|
Off-Label Use | 1 | 2020 | 185 | 0.040 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 531 | 0.040 |
Why?
|
Esophagus | 1 | 2004 | 1041 | 0.040 |
Why?
|
Breast | 1 | 2006 | 1972 | 0.040 |
Why?
|
Angiography, Digital Subtraction | 1 | 2018 | 331 | 0.030 |
Why?
|
Bacterial Adhesion | 1 | 1998 | 306 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13491 | 0.030 |
Why?
|
Infant | 1 | 2018 | 36485 | 0.030 |
Why?
|
Canada | 1 | 2021 | 2127 | 0.030 |
Why?
|
Pain | 2 | 2008 | 5101 | 0.030 |
Why?
|
Physical Examination | 2 | 2013 | 1265 | 0.030 |
Why?
|
Risk Assessment | 2 | 2013 | 24299 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5886 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2018 | 1104 | 0.030 |
Why?
|
Fertility | 1 | 2019 | 771 | 0.030 |
Why?
|
Outpatients | 1 | 2022 | 1600 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2020 | 5311 | 0.030 |
Why?
|
Workflow | 1 | 2019 | 859 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2013 | 6966 | 0.030 |
Why?
|
Abortion, Induced | 1 | 2019 | 471 | 0.030 |
Why?
|
Body Height | 1 | 2019 | 1565 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 3726 | 0.030 |
Why?
|
Algorithms | 1 | 2013 | 14098 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2021 | 1965 | 0.030 |
Why?
|
Databases, Factual | 1 | 2018 | 8068 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2016 | 1479 | 0.030 |
Why?
|
Animals | 9 | 2020 | 168965 | 0.020 |
Why?
|
Neoplasms | 2 | 2013 | 22350 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2018 | 39317 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2008 | 4282 | 0.020 |
Why?
|
Brain | 1 | 2018 | 27163 | 0.020 |
Why?
|
Hemothorax | 1 | 2011 | 58 | 0.020 |
Why?
|
Prospective Studies | 3 | 2021 | 54886 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2022 | 3488 | 0.020 |
Why?
|
Medical History Taking | 1 | 2013 | 779 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2902 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3618 | 0.020 |
Why?
|
Ankle Brachial Index | 1 | 2010 | 163 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2012 | 1374 | 0.020 |
Why?
|
Nitrogen Compounds | 1 | 2008 | 6 | 0.020 |
Why?
|
Phosphines | 1 | 2008 | 18 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2004 | 12986 | 0.020 |
Why?
|
Receptors, Bombesin | 1 | 2008 | 27 | 0.020 |
Why?
|
Acrylic Resins | 1 | 2008 | 131 | 0.020 |
Why?
|
Reoperation | 1 | 2018 | 4325 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2008 | 361 | 0.020 |
Why?
|
Drug Stability | 1 | 2008 | 289 | 0.020 |
Why?
|
Dogs | 1 | 2012 | 3834 | 0.020 |
Why?
|
Pain Measurement | 2 | 2008 | 3584 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2008 | 18330 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8732 | 0.020 |
Why?
|
Angioplasty | 1 | 2010 | 355 | 0.020 |
Why?
|
Limb Salvage | 1 | 2010 | 488 | 0.020 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2008 | 391 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2011 | 642 | 0.020 |
Why?
|
Isotope Labeling | 1 | 2008 | 390 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2009 | 832 | 0.020 |
Why?
|
Hydrazines | 1 | 2008 | 223 | 0.020 |
Why?
|
Patients' Rooms | 1 | 2006 | 63 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 1998 | 4424 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2011 | 877 | 0.020 |
Why?
|
Hematoma | 1 | 2011 | 766 | 0.020 |
Why?
|
Hemodynamics | 1 | 2016 | 4186 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2008 | 11097 | 0.020 |
Why?
|
Tumor Burden | 1 | 2011 | 1903 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15424 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2008 | 678 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 2012 | 0.010 |
Why?
|
Preoperative Care | 1 | 2013 | 2252 | 0.010 |
Why?
|
Lidocaine | 1 | 2008 | 545 | 0.010 |
Why?
|
Equipment Failure | 1 | 2007 | 585 | 0.010 |
Why?
|
Parenteral Nutrition, Total | 1 | 2005 | 304 | 0.010 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2008 | 388 | 0.010 |
Why?
|
Necrosis | 1 | 2008 | 1614 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2008 | 2275 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2008 | 1987 | 0.010 |
Why?
|
Models, Economic | 1 | 2008 | 719 | 0.010 |
Why?
|
Cysteine | 1 | 2008 | 896 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6844 | 0.010 |
Why?
|
Drug Design | 1 | 2008 | 1045 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 1331 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9410 | 0.010 |
Why?
|
Rabbits | 1 | 2008 | 4751 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2850 | 0.010 |
Why?
|
Anxiety | 2 | 2008 | 4670 | 0.010 |
Why?
|
Weight Loss | 1 | 2013 | 2716 | 0.010 |
Why?
|
Doxorubicin | 1 | 2008 | 2229 | 0.010 |
Why?
|
Syndrome | 1 | 2008 | 3271 | 0.010 |
Why?
|
Pancreas | 1 | 2008 | 1699 | 0.010 |
Why?
|
Anesthetics, Local | 1 | 2008 | 1005 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2013 | 3618 | 0.010 |
Why?
|
Digestive System Surgical Procedures | 1 | 2005 | 584 | 0.010 |
Why?
|
Survival Rate | 1 | 2013 | 12823 | 0.010 |
Why?
|
Child | 2 | 2005 | 80771 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2011 | 3324 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 59980 | 0.010 |
Why?
|
Renal Veins | 1 | 1998 | 103 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2702 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15925 | 0.010 |
Why?
|
Death | 1 | 2002 | 685 | 0.010 |
Why?
|
United States | 2 | 2020 | 72971 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2008 | 2662 | 0.010 |
Why?
|
Particulate Matter | 1 | 2009 | 2621 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8535 | 0.010 |
Why?
|
Ultrasonography | 1 | 2010 | 6000 | 0.010 |
Why?
|
Laparotomy | 1 | 1998 | 459 | 0.010 |
Why?
|
Body Mass Index | 1 | 2013 | 13048 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22254 | 0.010 |
Why?
|
Portal Vein | 1 | 1998 | 437 | 0.010 |
Why?
|
Health Care Costs | 1 | 2006 | 3239 | 0.010 |
Why?
|
Survival Analysis | 1 | 2005 | 10092 | 0.010 |
Why?
|
Pulmonary Veins | 1 | 1998 | 761 | 0.010 |
Why?
|
Melanoma | 1 | 2011 | 5702 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 17097 | 0.010 |
Why?
|
Mice | 1 | 2008 | 81912 | 0.000 |
Why?
|
Adolescent | 1 | 2005 | 89046 | 0.000 |
Why?
|